Neogen Chemicals updates on fire incident and insurance claim progress
Neogen Chemicals · Chemicals & Petrochemicals
Key highlights
- Fire occurred at Multi-Purpose Plant (MPP3), warehouse, and tank farms at Dahej SEZ on March 5, 2025.
- Fourth on-account insurance payment of ₹15 crore received on July 16, 2026; total claim received to date is ₹155 crore.
- Recognized loss of ₹348.16 crore (₹362.90 crore consolidated); production suspended with replacement plant commissioning planned for H1 FY27.
Why it's rated major development: operational disruption is always high
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Neogen Chemicals
- Fundraise / allotmentMajor developmentNeogen Chemicals reports Q2 FY27 revenues of ₹296 crore, 42% YoY growth
- Fundraise / allotmentMajor developmentNeogen Chemicals Sept-quarter results, ₹600 crore QIP and ₹200 crore NCD redemption plan
- Fundraise / allotmentMajor developmentNeogen Chemicals Q2 FY2026-27: QIP completed, standalone profit rises to ₹21.14 crore
- Fundraise / allotmentMajor developmentNeogen Chemicals reports Q2 FY 2026-27 results and QIP fund utilization update
- Fundraise / allotmentNotableNeogen Chemicals raises ~₹600 crore via first-ever QIP, oversubscribed over 6.5x
Other capex / expansion filings this fortnight
- Maharaja & Speedex India Limited raises manufacturing capacity to 72 lakh units/year
- Elin Electronics Q2 FY27 earnings report with 10% revenue growth and margin update
- HOAC Foods India Limited H1 FY27 Earnings Call Transcript dated November 5, 2026
- Gujarat State Fertilizers & Chemicals Limited Q2 FY27 Earnings Call Highlights
- Supriya Lifescience H1 revenue up 14.8% to ₹396.04 crore; Q2 profit falls
- V-MARC India Ltd announces Q2 & H1 FY27 unaudited financial results and review report
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- 3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.